Cited In for PMID: 26257441

Year	Number of Results
2015	2
2017	2
2018	1
2021	3
2024	1

1

Evolution of a thienopyrimidine antitubercular relying on medicinal chemistry and metabolomics insights.

Li SG, Vilchèze C, Chakraborty S, Wang X, Kim H, Anisetti M, Ekins S, Rhee KY, Jacobs WR Jr, Freundlich JS. Li SG, et al. Tetrahedron Lett. 2015 Jun 3;56(23):3246-3250. doi: 10.1016/j.tetlet.2015.02.129. Tetrahedron Lett. 2015. PMID: 26257441 Free PMC article.

2

Antimicrobial Evaluation of Sulfonamides after Coupling with Thienopyrimidine Coplanar Structure.

Elmongy EI, Alanazi WS, Aldawsari AI, Alfaouri AA, Binsuwaidan R. Elmongy EI, et al. Pharmaceuticals (Basel). 2024 Jan 31;17(2):188. doi: 10.3390/ph17020188. Pharmaceuticals (Basel). 2024. PMID: 38399403 Free PMC article.

3

Deciphering the mechanism of action of antitubercular compounds with metabolomics.

Sakallioglu IT, Barletta RG, Dussault PH, Powers R. Sakallioglu IT, et al. Comput Struct Biotechnol J. 2021 Jul 30;19:4284-4299. doi: 10.1016/j.csbj.2021.07.034. eCollection 2021. Comput Struct Biotechnol J. 2021. PMID: 34429848 Free PMC article. Review.

4

Targeting Mycobacterium tuberculosis response to environmental cues for the development of effective antitubercular drugs.

Lavin RC, Johnson C, Ahn YM, Kremiller KM, Sherwood M, Patel JS, Pan Y, Russo R, MacGilvary NJ, Giacalone D, Kevorkian YL, Zimmerman MD, Glickman JF, Freundlich JS, Tan S. Lavin RC, et al. PLoS Biol. 2021 Jul 28;19(7):e3001355. doi: 10.1371/journal.pbio.3001355. eCollection 2021 Jul. PLoS Biol. 2021. PMID: 34319985 Free PMC article.

5

Design, synthesis, crystal structure and anti-plasmodial evaluation of tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine derivatives.

Pal K, Raza MK, Legac J, Ataur Rahman M, Manzoor S, Rosenthal PJ, Hoda N. Pal K, et al. RSC Med Chem. 2021 May 18;12(6):970-981. doi: 10.1039/d1md00038a. eCollection 2021 Jun 23. RSC Med Chem. 2021. PMID: 34223162 Free PMC article.

6

Novel Pyrimidines as Antitubercular Agents.

Inoyama D, Paget SD, Russo R, Kandasamy S, Kumar P, Singleton E, Occi J, Tuckman M, Zimmerman MD, Ho HP, Perryman AL, Dartois V, Connell N, Freundlich JS. Inoyama D, et al. Antimicrob Agents Chemother. 2018 Feb 23;62(3):e02063-17. doi: 10.1128/AAC.02063-17. Print 2018 Mar. Antimicrob Agents Chemother. 2018. PMID: 29311070 Free PMC article.

7

Addressing the Metabolic Stability of Antituberculars through Machine Learning.

Stratton TP, Perryman AL, Vilchèze C, Russo R, Li SG, Patel JS, Singleton E, Ekins S, Connell N, Jacobs WR Jr, Freundlich JS. Stratton TP, et al. ACS Med Chem Lett. 2017 Sep 14;8(10):1099-1104. doi: 10.1021/acsmedchemlett.7b00299. eCollection 2017 Oct 12. ACS Med Chem Lett. 2017. PMID: 29057058 Free PMC article.

8

Antimycobacterial Metabolism: Illuminating Mycobacterium tuberculosis Biology and Drug Discovery.

Awasthi D, Freundlich JS. Awasthi D, et al. Trends Microbiol. 2017 Sep;25(9):756-767. doi: 10.1016/j.tim.2017.05.007. Epub 2017 Jun 13. Trends Microbiol. 2017. PMID: 28622844 Free PMC article. Review.

9

Combining Metabolite-Based Pharmacophores with Bayesian Machine Learning Models for Mycobacterium tuberculosis Drug Discovery.

Ekins S, Madrid PB, Sarker M, Li SG, Mittal N, Kumar P, Wang X, Stratton TP, Zimmerman M, Talcott C, Bourbon P, Travers M, Yadav M, Freundlich JS. Ekins S, et al. PLoS One. 2015 Oct 30;10(10):e0141076. doi: 10.1371/journal.pone.0141076. eCollection 2015. PLoS One. 2015. PMID: 26517557 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

9 results

Results by year